What are the appropriate loading and maintenance doses of phenytoin for a 60‑kg adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Phenytoin Dosing for a 60-kg Adult

For a 60-kg adult, administer a loading dose of 900–1,200 mg (15–20 mg/kg) intravenously at a maximum rate of 50 mg/minute, followed by a maintenance dose of 300–400 mg/day (5–6.7 mg/kg/day) divided into doses every 6–8 hours or given once daily. 1, 2

Loading Dose Administration

Dose Calculation

  • Standard loading dose: 15–20 mg/kg IV 1, 2
  • For a 60-kg patient: This translates to 900–1,200 mg total dose 1, 2
  • Preferred dose: 18 mg/kg (1,080 mg for 60 kg) achieves therapeutic levels (>10 mcg/mL) in 97% of patients immediately after infusion 3

Infusion Rate and Timing

  • Maximum infusion rate: 50 mg/minute in adults 1, 2
  • Infusion duration: A 1,000-mg loading dose administered at 50 mg/min requires approximately 20 minutes 2
  • Never exceed 50 mg/min: Rapid administration causes hypotension, bradycardia, cardiac arrhythmias, and cardiac arrest 1, 3

Critical Safety Monitoring During Infusion

  • Continuous ECG monitoring is mandatory to detect bradycardia, arrhythmias, and heart block 1
  • Blood pressure monitoring throughout infusion to detect hypotension 1, 3
  • Reduce infusion rate if heart rate decreases by 10 beats/min 1
  • Respiratory monitoring for signs of respiratory depression 2

Administration Preparation

  • Dilute only in normal saline with final concentration ≥5 mg/mL 1
  • Never mix with dextrose solutions: This causes precipitation 1, 3
  • Avoid intramuscular administration for acute seizures due to erratic absorption and risk of tissue necrosis; peak levels may require up to 24 hours 2

Maintenance Dose Regimen

Standard Maintenance Dosing

  • Initial maintenance dose: 300 mg daily, which can be given as a single daily dose or divided (100 mg three times daily) 4
  • Typical maintenance range: 200–700 mg/day (approximately 4–6 mg/kg/day for a 60-kg patient) 1, 4
  • Timing: Begin maintenance dosing every 6–8 hours after the loading dose 2

For a 60-kg Patient Specifically

  • Standard starting dose: 300 mg/day (5 mg/kg/day) 4
  • Upper range if needed: 400 mg/day (6.7 mg/kg/day) 1
  • Dose adjustments: Increase incrementally by 100–200 mg/day at weekly intervals if levels are subtherapeutic, with maximum typical adult dose of 1,200 mg/day 4

Therapeutic Level Achievement and Monitoring

Expected Time to Therapeutic Levels

  • IV loading: Therapeutic levels (10–20 mcg/mL) achieved within 10 minutes of infusion completion 4
  • Confirmation timing: Check level 2–4 hours after completion to confirm sustained therapeutic concentrations 4
  • Critical monitoring point: At 12 hours post-loading, approximately 50% of patients may have subtherapeutic levels 4
  • 24-hour stability: Most patients (approximately 83%) maintain therapeutic levels at 24 hours after appropriate loading 4

Ongoing Monitoring Strategy

  • First level check: 2–4 hours after loading dose completion 4
  • Trough levels: Obtain just prior to next scheduled dose to assess therapeutic range 2
  • Peak levels: Obtained at time of expected peak concentration to identify threshold for dose-related toxicity 2
  • Steady-state timing: Without loading, regular oral maintenance dosing takes 3–7 days to achieve therapeutic levels 4

Important Clinical Caveats

Dose-Related Adverse Effects to Monitor

  • Common toxicity signs: Ataxia, nystagmus, tremor, somnolence, and cognitive impairment 1, 4
  • Cardiovascular risks: Approximately 2% experience bradycardia and 2% experience arrhythmias 3
  • Local reactions: Approximately 15% may experience irritation at infusion site 3
  • Extravasation risk: Can cause severe tissue necrosis due to high alkalinity 1

Alternative: Fosphenytoin Advantages

  • Faster administration: Can be infused at 150 mg PE/min (three times faster than phenytoin) 1, 4, 3
  • Loading dose: 18–20 mg PE/kg IV 1
  • Reduced complications: Less hypotension, reduced local irritation, and can be given intramuscularly if needed 1, 3

Special Population Considerations

  • Overweight patients (>120% ideal body weight): Use adjusted body weight rather than actual body weight for loading dose calculation to avoid supratherapeutic levels 5
  • Renal/hepatic impairment or hypoalbuminemia: Monitor unbound (free) phenytoin concentrations rather than total levels 4, 2

References

Guideline

Phenytoin Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Dosis Recomendada de Fenitoína para el Estado Epiléptico

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Monitoring Phenytoin Levels for Optimal Seizure Control

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the conversion protocol for switching from oral (po) phenytoin to intravenous (IV) phenytoin?
How should I give a phenytoin loading dose to a 70‑kg adult, including the total dose, dilution volume, infusion rate (max 50 mg/min), and required cardiac monitoring?
What is the recommended dosage of phenytoin?
What is the recommended infusion dose of phenytoin for seizure treatment?
What is the proper administration protocol for phenytoin (antiepileptic medication)?
What is the appropriate diagnostic work‑up and immediate management for a patient presenting with upper abdominal pain, fatigue, visible jaundice, and a markedly elevated alkaline phosphatase?
What is the loading dose and maintenance regimen of carbamazepine (Eptoin) for a 60‑kg adult?
In a patient with epigastric pain radiating to the mid back, no evidence of acute cholecystitis, and ultrasound showing cholelithiasis, what is the next step in management?
What is the appropriate treatment for acute bronchitis presenting with green, productive sputum?
What is the recommended starting dose, titration schedule, and maximum dose of Luvox (fluvoxamine) for adults, children/adolescents, and elderly patients, including any special considerations such as hepatic impairment and MAOI interactions?
In a patient with normal liver function tests, normal lipase, and ultrasound showing no acute cholecystitis or common bile duct dilation but persistent epigastric pain radiating to the mid‑back suggestive of symptomatic cholelithiasis, should I refer to a general surgeon for elective cholecystectomy rather than to gastroenterology?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.